Clinical outcomes in patients with metastatic renal cell carcinoma and brain metastasis treated with ipilimumab and nivolumab

• Tian Zhang,
• Brian I. Rini,
• Moshe C. Ornstein,
• Daniel J. George,
• Chester Kao,
• Landon C. Brown,
• Kunal Desai,
• Emily N. Kinsey

Affiliations

Tian Zhang

Department of Medicine, Center for Prostate & Urologic Cancers, Duke Cancer Institute, Durham, North Carolina, USA

Brian I. Rini

Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, USA

Moshe C. Ornstein

Taussig Cancer Institute, Cleveland, Ohio, USA

Daniel J. George

Department of Medicine, Center for Prostate & Urologic Cancers, Duke Cancer Institute, Durham, North Carolina, USA

Chester Kao

Department of Medicine, Center for Prostate & Urologic Cancers, Duke Cancer Institute, Durham, North Carolina, USA

Landon C. Brown

Department of Medicine, Center for Prostate & Urologic Cancers, Duke Cancer Institute, Durham, North Carolina, USA

Kunal Desai

Department of Internal Medicine, Cleveland Clinic, Cleveland, Ohio, USA

Emily N. Kinsey

Department of Medicine, Center for Prostate & Urologic Cancers, Duke Cancer Institute, Durham, North Carolina, USA